Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

25.08
-0.2700-1.07%
Pre-market: 25.800.7200+2.87%07:12 EDT
Volume:2.16M
Turnover:54.13M
Market Cap:3.14B
PE:116.43
High:25.67
Open:25.49
Low:24.73
Close:25.35
52wk High:31.77
52wk Low:15.10
Shares:125.07M
Float Shares:111.18M
Volume Ratio:1.19
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2154
EPS(LYR):-0.1269
ROE:15.86%
ROA:5.09%
PB:14.22
PE(LYR):-197.70

Loading ...

Arcutis Grants 61,000 Rsus to Nine New Hires Under 2022 Inducement Plan

Reuters
·
Jul 03

Arcutis Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Arcutis Biotherapeutics - Launches Virtual Health Platform to Expand Access to Zoryve Portfolio

THOMSON REUTERS
·
Jun 30

Arcutis Biotherapeutics Wins FDA Approval For Expanded Pediatric Skin Drug Use

MT Newswires Live
·
Jun 30

FDA approves supplemental NDA to expand indication of Arcutis’ Zoryve cream

TIPRANKS
·
Jun 30

Arcutis Says FDA Approves Zoryve Cream for Plaque Psoriasis in Children as Young as 2

Reuters
·
Jun 30

FDA Approves Arcutis’ Zoryve® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

THOMSON REUTERS
·
Jun 30

Arcutis Biotherapeutics director Howard G. Welgus disposes of 4,731 common shares for $115,957.48

Reuters
·
Jun 18

Arcutis Stockholders Approve Proposals at 2026 Meeting

TIPRANKS
·
Jun 10

Arcutis Biotherapeutics shareholders elect Class III directors at annual meeting

Reuters
·
Jun 10

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 06

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 03

Arcutis Biotherapeutics to present at Goldman Sachs Global Healthcare Conference

Reuters
·
May 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Abivax SA Sponsored ADR (ABVX) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
May 26

Arcutis Earnings Call Signals Momentum Amid Headwinds

TIPRANKS
·
May 11

Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4

Reuters
·
May 09

Arcutis grants 269,000 RSUs, 70,000 stock options to new hires under inducement plan

Reuters
·
May 09

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 09

Arcutis Biotherapeutics price target lowered to $34 from $35 at Morgan Stanley

TIPRANKS
·
May 08

Stock Track | Arcutis Biotherapeutics Plunges 5.23% in Pre-market Following Q1 Earnings Miss and Insider Selling

Stock Track
·
May 07